Free Trial

Talis Biomedical Q4 2022 Earnings Report

Talis Biomedical logo
$1.57 -0.33 (-17.37%)
As of 03:36 PM Eastern

Talis Biomedical EPS Results

Actual EPS
-$15.00
Consensus EPS
-$11.40
Beat/Miss
Missed by -$3.60
One Year Ago EPS
N/A

Talis Biomedical Revenue Results

Actual Revenue
$0.26 million
Expected Revenue
$0.50 million
Beat/Miss
Missed by -$240.00 thousand
YoY Revenue Growth
N/A

Talis Biomedical Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

Talis Biomedical Earnings Headlines

Talis Biomedical Corp Ordinary Shares
Do this Before Elon’s Reveal on January 29th
Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.
See More Talis Biomedical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Talis Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Talis Biomedical and other key companies, straight to your email.

About Talis Biomedical

Talis Biomedical (NASDAQ:TLIS) operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.

View Talis Biomedical Profile

More Earnings Resources from MarketBeat